{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:46:21Z","timestamp":1788907581740,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04367-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:58:16Z","timestamp":1783130296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence"],"prefix":"10.1007","volume":"49","author":[{"given":"Joyce","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryanna Rather","family":"Eguh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Boockvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"8","key":"4367_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"issue":"3","key":"4367_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jmri.28743park","volume":"58","author":"YW Park","year":"2023","unstructured":"Park YW, Vollmuth P, Foltyn-Dumitru M et al (2023) The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas. J Magn Reson Imaging 58(3):677\u2013689. https:\/\/doi.org\/10.1002\/jmri.28743park","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"4367_CR3","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/curroncol31070296","volume":"31","author":"Mea Jezierza\u0144ski","year":"2024","unstructured":"Jezierza\u0144ski Mea et al (2024) Temozolomide (TMZ) in the treatment of glioblastoma multiforme-a literature review and clinical outcomes. Curr Oncol 31(7):3994\u20134002. https:\/\/doi.org\/10.3390\/curroncol31070296","journal-title":"Curr Oncol"},{"key":"4367_CR4","doi-asserted-by":"publisher","unstructured":"\u0106wikli\u0144ska Aea et al (2024) Innovative approaches to brain cancer: the use of magnetic resonance-guided focused ultrasound in glioma therapy. Cancers (Basel) 16(24):4235, 4235. https:\/\/doi.org\/10.3390\/cancers16244235","DOI":"10.3390\/cancers16244235"},{"key":"4367_CR5","doi-asserted-by":"publisher","unstructured":"Hersh AM (2022) Applications of focused ultrasound for the treatment of glioblastoma: a new frontier. Cancers (Basel) 14(19):4920, 4920. https:\/\/doi.org\/10.3390\/cancers14194920","DOI":"10.3390\/cancers14194920"},{"key":"4367_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1387986","author":"DC Nwafor","year":"2024","unstructured":"Nwafor DC (2024) Focused ultrasound as a treatment modality for gliomas. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2024.1387986","journal-title":"Front Neurol"},{"issue":"10","key":"4367_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"2","key":"4367_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11060-022-03974-0","volume":"157","author":"JW Roberts","year":"2022","unstructured":"Roberts JW (2022) Focused ultrasound for the treatment of glioblastoma. J Neurooncol 157(2):237\u2013247. https:\/\/doi.org\/10.1007\/s11060-022-03974-0","journal-title":"J Neurooncol"},{"issue":"2","key":"4367_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","volume":"134","author":"SH Park","year":"2020","unstructured":"Park SH, Kim MJ, Jung HH et al (2020) Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg 134(2):475\u2013483. https:\/\/doi.org\/10.3171\/2019.10.JNS192206","journal-title":"J Neurosurg"},{"key":"4367_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"12","key":"4367_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/s1470-2045(25)00492-9_","volume":"26","author":"GF Woodworth","year":"2025","unstructured":"Woodworth GF et al (2025) Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1\/2 trial. Lancet Oncol 26(12):1651\u20131664. https:\/\/doi.org\/10.1016\/s1470-2045(25)00492-9_","journal-title":"Lancet Oncol"},{"key":"4367_CR12","doi-asserted-by":"publisher","unstructured":"Dalinina VD (2025) Effect of acoustic pressure on temozolomide-loaded oleic acid-based liposomes and its safety to brain tissue. Pharmaceuticals (Basel) 18(6):910, 910. https:\/\/doi.org\/10.3390\/ph18060910","DOI":"10.3390\/ph18060910"},{"key":"4367_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2024.06.036","volume":"372","author":"Nea McDannold","year":"2024","unstructured":"McDannold Nea et al (2024) Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma. J Control Release 372:194\u2013208. https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.036","journal-title":"J Control Release"},{"key":"4367_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6501508","volume":"2018","author":"Q Dong","year":"2018","unstructured":"Dong Q et al (2018) Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent. Biomed Res Int 2018:1\u20139. https:\/\/doi.org\/10.1155\/2018\/6501508","journal-title":"Biomed Res Int"},{"issue":"3","key":"4367_CR15","doi-asserted-by":"publisher","first-page":"e58995","DOI":"10.1371\/journal.pone.0058995","volume":"8","author":"K-C Wei","year":"2013","unstructured":"Wei K-C et al (2013) Focused Ultrasound-Induced Blood\u2013Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study. PLoS ONE 8(3):e58995. https:\/\/doi.org\/10.1371\/journal.pone.0058995","journal-title":"PLoS ONE"},{"key":"4367_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2018.12.009","volume":"295","author":"Aea Papachristodoulou","year":"2018","unstructured":"Papachristodoulou Aea et al (2018) Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes. J Control Release 295:130\u2013139. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.009","journal-title":"J Control Release"},{"issue":"8","key":"4367_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081270","volume":"13","author":"Zea Song","year":"2021","unstructured":"Song Zea et al (2021) Targeted delivery of liposomal temozolomide enhanced anti-glioblastoma efficacy through ultrasound-mediated blood\u2013brain barrier opening. Pharmaceutics 13(8):1270. https:\/\/doi.org\/10.3390\/pharmaceutics13081270","journal-title":"Pharmaceutics"},{"key":"4367_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-025-00695-0","author":"Jea Shin","year":"2025","unstructured":"Shin Jea et al (2025) Focused ultrasound-mediated temozolomide delivery into intact blood\u2013brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma. Fluids Barriers CNS. https:\/\/doi.org\/10.1186\/s12987-025-00695-0","journal-title":"Fluids Barriers CNS"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04367-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04367-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04367-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:02:19Z","timestamp":1783173739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04367-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4367"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04367-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}